Alua Kabdolova joined the SauvageauLab
Welcome to Alua Kabdolova our new member!
A Sauvageau Lab PhD student receives an important grant
Vincent-Philippe Lavallée, a PhD student in the Sauvageau lab, received an important grant from the Vanier Canada Graduate Scholarship (Vanier CGS) program. This 3-year scholarship from the Canadian Institutes of Health Research (CIHR), rewards students that distinguish themselves for their leadership and academic excellence.
Accepting applications for exceptional PhD students
The Sauvageau lab currently accepting applications for exceptional PhD students. If you are passionate about research and interested in joining our team, please submit your application to Marie-Eve Bordeleau.
ExCellThera wins the first prize at the HealthKick Challenge in Toronto
ExCellThera, a clinical-stage spin-off company based on the Sauvageau lab’s work on stem cell expansion, won the $20,000 first prize in the Pharma and Biotech category at the HealthKick Challenge, which took place in Toronto, Ontario, on April 5th.
Health Canada authorizes a clinical trial for the UM171 molecule
Health Canada has officially given the green light for the first phase of clinical trials involving transplantation of cord blood cells expanded with the small molecule UM171 for the treatment of blood-related cancers. Thanks to our collaborators at IRIC and Hôpital Maisonneuve-Rosemont
The Leucegene project has a new website
Visit the new Leucegene website. Several of our lab members are involved in this project.
UM171 – Voted Québec Science Discovery of the Year
The public has voted this scientific breakthrough 2014 Québec Science Discovery of the Year.
Simon Fortier, one of our PhD student, publishes in PNAS
Haploinsufficiency screen highlights two distinct groups of ribosomal protein genes essential for embryonic stem cell fate